Scott Praill
2017
In 2017, Scott Praill earned a total compensation of $379.6K as Chief Financial Officer at DelMar Pharmaceuticals, a 153% increase compared to previous year.
Compensation breakdown
| Bonus | $40,000 |
|---|---|
| Option Awards | $99,596 |
| Salary | $240,000 |
| Total | $379,596 |
Praill received $240K in salary, accounting for 63% of the total pay in 2017.
Praill also received $40K in bonus and $99.6K in option awards.
Rankings
In 2017, Scott Praill's compensation ranked 12,738th out of 14,666 executives tracked by ExecPay. In other words, Praill earned more than 13.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,738 out of 14,666 | 13th |
Division Manufacturing | 5,006 out of 5,768 | 13th |
Major group Chemicals And Allied Products | 1,835 out of 2,074 | 12th |
Industry group Drugs | 1,528 out of 1,730 | 12th |
Industry Pharmaceutical Preparations | 1,183 out of 1,329 | 11th |
Source: SEC filing on March 9, 2018.
Praill's colleagues
We found two more compensation records of executives who worked with Scott Praill at DelMar Pharmaceuticals in 2017.